Literature DB >> 20441566

Role of phosphoinositide 3-kinase beta in platelet aggregation and thromboxane A2 generation mediated by Gi signalling pathways.

Analia Garcia1, Soochong Kim, Kamala Bhavaraju, Simone M Schoenwaelder, Satya P Kunapuli.   

Abstract

PI3Ks (phosphoinositide 3-kinases) play a critical role in platelet functional responses. PI3Ks are activated upon P2Y12 receptor stimulation and generate pro-aggregatory signals. P2Y12 receptor has been shown to play a key role in the platelet aggregation and thromboxane A2 generation caused by co-stimulation with Gq or Gz, or super-stimulation of Gi pathways. In the present study, we evaluated the role of specific PI3K isoforms alpha, beta, gamma and delta in platelet aggregation, thromboxane A2 generation and ERK (extracellular-signal-regulated kinase) activation. Our results show that loss of the PI3K signal impaired the ability of ADP to induce platelet aggregation, ERK phosphorylation and thromboxane A2 generation. We also show that Gq plus Gi- or Gi plus Gz-mediated platelet aggregation, ERK phosphorylation and thromboxane A2 generation in human platelets was inhibited by TGX-221, a PI3Kbeta-selective inhibitor, but not by PIK75 (a PI3Kalpha inhibitor), AS252424 (a PI3Kgamma inhibitor) or IC87114 (a PI3Kdelta inhibitor). TGX-221 also showed a similar inhibitory effect on the Gi plus Gz-mediated platelet responses in platelets from P2Y1-/- mice. Finally, 2MeSADP (2-methyl-thio-ADP)-induced Akt phosphorylation was significantly inhibited in the presence of TGX-221, suggesting a critical role for PI3Kbeta in Gi-mediated signalling. Taken together, our results demonstrate that PI3Kbeta plays an important role in ADP-induced platelet aggregation. Moreover, PI3Kbeta mediates ADP-induced thromboxane A2 generation by regulating ERK phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20441566     DOI: 10.1042/BJ20100166

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets.

Authors:  Bhanu Kanth Manne; Rachit Badolia; Carol Dangelmaier; Johannes A Eble; Wilfried Ellmeier; Mark Kahn; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2015-03-12       Impact factor: 5.157

2.  RGS10 shapes the hemostatic response to injury through its differential effects on intracellular signaling by platelet agonists.

Authors:  Peisong Ma; Shuchi Gupta; Sara Sampietro; Daniel DeHelian; Valerie Tutwiler; Alan Tang; Timothy J Stalker; Lawrence F Brass
Journal:  Blood Adv       Date:  2018-08-28

3.  Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation.

Authors:  M Endale; W M Lee; S M Kamruzzaman; S D Kim; J Y Park; M H Park; T Y Park; H J Park; J Y Cho; M H Rhee
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 4.  The role of P2Y₁₂ receptor and activated platelets during inflammation.

Authors:  Elisabetta Liverani; Laurie E Kilpatrick; Alexander Y Tsygankov; Satya P Kunapuli
Journal:  Curr Drug Targets       Date:  2014       Impact factor: 3.465

Review 5.  Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties.

Authors:  Nicola Ferri; Alberto Corsini; Stefano Bellosta
Journal:  Drugs       Date:  2013-10       Impact factor: 9.546

6.  PDK1 selectively phosphorylates Thr(308) on Akt and contributes to human platelet functional responses.

Authors:  C Dangelmaier; B K Manne; E Liverani; J Jin; P Bray; S P Kunapuli
Journal:  Thromb Haemost       Date:  2013-12-19       Impact factor: 5.249

7.  PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway.

Authors:  B K Manne; P Münzer; R Badolia; B Walker-Allgaier; R A Campbell; E Middleton; A S Weyrich; S P Kunapuli; O Borst; M T Rondina
Journal:  J Thromb Haemost       Date:  2018-05-08       Impact factor: 5.824

8.  Prasugrel metabolites inhibit neutrophil functions.

Authors:  Elisabetta Liverani; Mario C Rico; Analia E Garcia; Laurie E Kilpatrick; Satya P Kunapuli
Journal:  J Pharmacol Exp Ther       Date:  2012-10-24       Impact factor: 4.030

9.  Development of inhibitors of heterotrimeric Gαi subunits.

Authors:  Kathryn M Appleton; Kevin J Bigham; Christopher C Lindsey; Starr Hazard; Jonel Lirjoni; Stuart Parnham; Mirko Hennig; Yuri K Peterson
Journal:  Bioorg Med Chem       Date:  2014-04-26       Impact factor: 3.641

10.  Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα.

Authors:  Caroline Kardeby; Knut Fälker; Elizabeth J Haining; Maarten Criel; Madelene Lindkvist; Ruben Barroso; Peter Påhlsson; Liza U Ljungberg; Mattias Tengdelius; G Ed Rainger; Stephanie Watson; Johannes A Eble; Marc F Hoylaerts; Jonas Emsley; Peter Konradsson; Steve P Watson; Yi Sun; Magnus Grenegård
Journal:  Blood Adv       Date:  2019-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.